Haemonetics
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $357,759 | $339,380 | $346,351 | $338,967 |
Gross Profit | 220,913 | 202,803 | 198,212 | 191,406 |
EBITDA | 102,880 | 74,685 | 4,294 | 95,482 |
EBIT | 75,120 | 47,574 | -23,025 | 68,097 |
Net Income | 46,305 | 33,010 | -20,147 | 44,740 |
Net Change In Cash | 357,759 | 339,380 | 346,351 | 338,967 |
Free Cash Flow | 118,894 | 44,417 | 53,280 | 87,215 |
Cash | 260,712 | 223,384 | 245,440 | 363,367 |
Basic Shares | 46,463 | 45,704 | 46,224 | 46,987 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $1,334,027 | $1,360,824 | $1,309,055 | $1,168,660 |
Gross Profit | 743,588 | 778,546 | 711,915 | 622,873 |
EBITDA | 268,451 | 362,686 | 304,052 | 260,507 |
EBIT | 156,734 | 247,100 | 206,837 | 167,200 |
Net Income | 97,308 | 167,679 | 117,558 | 115,401 |
Net Change In Cash | 1,334,027 | 1,360,824 | 1,309,055 | 1,168,660 |
Cost of Revenue | 28,906 | |||
Free Cash Flow | 260,440 | 142,447 | 143,626 | 162,867 |
Cash | 245,440 | 306,763 | 178,800 | 284,466 |
Basic Shares | 47,354 | 50,730 | 51,397 | 51,420 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | $1.35 |
2026-06-30 | $1.14 |
2026-03-31 | $1.29 |
2025-12-31 | $1.31 |